CONSTANT-INFUSION RECOMBINANT INTERLEUKIN-2 IN ADOPTIVE IMMUNOTHERAPY OF ADVANCED CANCER

被引：1292
|
作者：
WEST, WH
TAUER, KW
YANNELLI, JR
MARSHALL, GD
ORR, DW
THURMAN, GB
OLDHAM, RK
机构：
[1] BIOL THERAPY INST,MEMPHIS,TN
[2] BIOTHERAPEUT INC,FRANKLIN,TN
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1987年 / 316卷 / 15期
关键词：
D O I：
10.1056/NEJM198704093161502
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：898 / 905
页数：8
相关论文
共 50 条
  • [41] NEPHROTOXICITY OF CONTINUOUS INTRAVENOUS-INFUSION OF RECOMBINANT INTERLEUKIN-2
    CHRISTIANSEN, NP
    SKUBITZ, KM
    NATH, K
    OCHOA, A
    KENNEDY, BJ
    AMERICAN JOURNAL OF MEDICINE, 1988, 84 (06): : 1072 - 1075
  • [42] High-dose recombinant interleukin-2/verapamil combination in advanced cancer
    Tagliaferri, P
    Correale, P
    Mottola, M
    deSimone, G
    Montesarchio, V
    Matano, E
    Rea, A
    Morabito, A
    Famiani, M
    Ciardiello, F
    Tortora, G
    Caraglia, M
    Barile, C
    Palmieri, G
    Bianco, AR
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (08) : 1436 - 1437
  • [43] THE EFFECT OF RECOMBINANT INTERLEUKIN-2 IN COMBINATION WITH MITOMYCIN-C ON ADVANCED CANCER
    AKIYOSHI, T
    ARINAGA, S
    NANBARA, S
    KARIMINE, N
    INOUE, H
    TAKAMUKU, K
    ABE, R
    WATANABE, D
    NAGAMATSU, M
    MATSUOKA, H
    UEO, H
    JAPANESE JOURNAL OF SURGERY, 1990, 20 (03): : 365 - 368
  • [44] Local immunotherapy of purulent sinusitis by recombinant human interleukin-2
    Totolian, A
    Lavrenova, G
    Galkina, O
    Katinas, E
    Smirnov, M
    Buravtsova, N
    Aleshina, L
    5TH WORLD CONGRESS ON TRAUMA, SHOCK, INFLAMMATION AND SEPSIS: PATHOPHYSIOLOGY, IMMUNE CONSEQUENCES AND THERAPY, 2000, : 307 - 311
  • [45] ADOPTIVE IMMUNOTHERAPY WITH LYMPHOKINE ACTIVATED KILLER CELLS PLUS RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA
    ONISHI, S
    SAIBARA, T
    SAKAEDA, H
    MATSUURA, Y
    FUJIKAWA, M
    MATSUNAGA, Y
    IDO, A
    IWAMURA, S
    TOMITA, T
    YAMAMOTO, Y
    HEPATOLOGY, 1988, 8 (05) : 1287 - 1287
  • [46] INTERSTITIAL NEPHRITIS IN A PATIENT RECEIVING ADOPTIVE IMMUNOTHERAPY WITH RECOMBINANT INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS
    FEINFELD, DA
    DAGATI, V
    DUTCHER, JP
    WERFEL, SB
    LYNN, RI
    WIERNIK, PH
    AMERICAN JOURNAL OF NEPHROLOGY, 1991, 11 (06) : 489 - 492
  • [47] Homing of radiolabelled recombinant interleukin-2 activated natural killer cells and their efficacy in adoptive immunotherapy against murine fibrosarcoma
    Anuradha Rai
    Ashim K. Chakravarty
    Journal of Biosciences, 2007, 32 : 1299 - 1305
  • [48] RECOMBINANT INTERLEUKIN-2 AND RECOMBINANT INTERFERON-ALPHA IMMUNOTHERAPY CARDIOVASCULAR TOXICITY
    SCHECHTER, D
    NAGLER, A
    AMERICAN HEART JOURNAL, 1992, 123 (06) : 1736 - 1739
  • [49] RECOMBINANT INTERLEUKIN-2 AND ADOPTIVE IMMUNOTHERAPY ALTERNATED WITH DACARBAZINE THERAPY IN MELANOMA - A NATIONAL BIOTHERAPY STUDY-GROUP TRIAL
    DILLMAN, RO
    OLDHAM, RK
    BARTH, NM
    BIRCH, R
    ARNOLD, J
    WEST, WH
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (16) : 1345 - 1349
  • [50] Homing of radiolabelled recombinant interleukin-2 activated natural killer cells and their efficacy in adoptive immunotherapy against murine fibrosarcoma
    Rai, Anuradha
    Chakravarty, Ashim K.
    JOURNAL OF BIOSCIENCES, 2007, 32 (03) : 1299 - 1305
12345